References
- Lo SS, Chang EL, Suh J. Stereotactic radiosurgery with and without whole-brain radiotherapy for newly diagnosed brain metastases. Expert Rev. Neurotherapeutics 5(4), 487–495 (2005).
- Patchell RA, Tibbs PA, Regine WF et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280(17), 1485–1489 (1998).
- DeAngelis LM, Mandell LR, Thaler HT et al. The role of postoperative radiotherapy after resection of single brain metastases. Neurosurg. 24, 798–805 (1989).
- Meyers CA, Smith JA, Bezjak A et al. Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized Phase III trial. J Clin. Oncol. 22(1), 157–165 (2004).
- Andrews DW, Scott CB, Sperduto PW et al. Whole-brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet. 363(9422), 1665–1672 (2004).
- Mañon R, Oneill A, Mehta M et al. Phase II trial of radiosurgery (RS) for 1 to 3 newly diagnosed brain metastases from renal cell, melanoma, and sarcoma: An Eastern Cooperative Oncology Group Study (E6397). J. Clin. Oncol. ASCO Annual Meeting Proceedings (Post Meeting Edition). 22, 14S, (Abstract).
- Aoyama H. ASCO Annual Meeting Proceedings (Post Meeting Edition). J. Clin. Oncol. 22, 18S(Abstract) (2004).